Literature DB >> 28351331

MiR-613 suppresses retinoblastoma cell proliferation, invasion, and tumor formation by targeting E2F5.

Yiting Zhang1, Xinyue Zhu1, Xiaomin Zhu2, Yan Wu2, Yajun Liu1, Borui Yao1, Zhenping Huang1.   

Abstract

Retinoblastoma is a common intraocular malignancy that occurs during childhood. MicroRNAs play critical roles in the regulation of retinoblastoma initiation and progression, and aberrant expression of miR-613 had been reported in various types of cancer. However, the role and mechanism of its function in retinoblastoma are still unclear. In this study, we found that miR-613 was downregulated in retinoblastoma tissues and cell lines. Overexpression of miR-613 suppressed retinoblastoma cell proliferation, migration, and invasion and induced cell cycle arrest in vitro. Additionally, overexpressed miR-613 also inhibited tumor formation of retinoblastoma cells in vivo. We further identified E2F5 as a direct target of miR-613. Reintroduction of E2F5 without 3'-untranslated region reversed the inhibitory effects of miR-613 on cell proliferation and invasion. Our data collectively indicate that miR-613 functions as a tumor suppressor in retinoblastoma through downregulating E2F5, supporting the targeting of the novel miR-613/E2F5 axis as a potentially effective therapeutic approach for retinoblastoma.

Entities:  

Keywords:  E2F5; Retinoblastoma; miR-613

Mesh:

Substances:

Year:  2017        PMID: 28351331     DOI: 10.1177/1010428317691674

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  23 in total

1.  MiR-195-5p inhibits proliferation and invasion of nerve cells in Hirschsprung disease by targeting GFRA4.

Authors:  Gang Wang; Hefeng Wang; Lijuan Zhang; Feng Guo; Xiangyu Wu; Yang Liu
Journal:  Mol Cell Biochem       Date:  2021-01-30       Impact factor: 3.396

2.  Suppression of Disheveled-Axin Domain Containing 1 (DIXDC1) by MicroRNA-186 Inhibits the Proliferation and Invasion of Retinoblastoma Cells.

Authors:  Xuanyi Che; Yuanjie Qian; Di Li
Journal:  J Mol Neurosci       Date:  2017-12-20       Impact factor: 3.444

3.  MicroRNA-1179 inhibits glioblastoma cell proliferation and cell cycle progression via directly targeting E2F transcription factor 5.

Authors:  Xiupeng Xu; Ning Cai; Tongle Zhi; Zhongyuan Bao; Dong Wang; Yinlong Liu; Kuan Jiang; Liang Fan; Jing Ji; Ning Liu
Journal:  Am J Cancer Res       Date:  2017-08-01       Impact factor: 6.166

Review 4.  Expression profiles and prognostic value of miRNAs in retinoblastoma.

Authors:  Lara Elis Alberici Delsin; Karina Bezerra Salomao; Julia Alejandra Pezuk; Maria Sol Brassesco
Journal:  J Cancer Res Clin Oncol       Date:  2018-10-22       Impact factor: 4.553

Review 5.  Biomarkers in retinoblastoma.

Authors:  Jie Sun; Hui-Yu Xi; Qing Shao; Qing-Huai Liu
Journal:  Int J Ophthalmol       Date:  2020-02-18       Impact factor: 1.779

6.  MicroRNA-9 inhibits proliferation and progression in retinoblastoma cells by targeting PTEN.

Authors:  Manhai Gao; Zhe Cui; Dan Zhao; Shurong Zhang; Qiang Cai
Journal:  Genes Genomics       Date:  2021-06-15       Impact factor: 1.839

7.  LncRNA LINC00152 Increases the Aggressiveness of Human Retinoblastoma and Enhances Carboplatin and Adriamycin Resistance by Regulating MiR-613/Yes-Associated Protein 1 (YAP1) Axis.

Authors:  Ying Wang; Danli Xin; Lei Zhou
Journal:  Med Sci Monit       Date:  2020-06-15

8.  LncRNA HOTAIR/miR-613/c-met axis modulated epithelial-mesenchymal transition of retinoblastoma cells.

Authors:  Ge Yang; Yang Fu; Xiaoyan Lu; Menghua Wang; Hongtao Dong; Qiuming Li
Journal:  J Cell Mol Med       Date:  2018-07-20       Impact factor: 5.310

9.  The putative tumour suppressor miR-1-3p modulates prostate cancer cell aggressiveness by repressing E2F5 and PFTK1.

Authors:  Sen-Mao Li; Huan-Lei Wu; Xiao Yu; Kun Tang; Shao-Gang Wang; Zhang-Qun Ye; Jia Hu
Journal:  J Exp Clin Cancer Res       Date:  2018-09-05

10.  MiR-140-5p suppresses retinoblastoma cell growth via inhibiting c-Met/AKT/mTOR pathway.

Authors:  Yujun Liao; Xiaolong Yin; Yan Deng; Xiaowei Peng
Journal:  Biosci Rep       Date:  2018-11-30       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.